Cargando…

Foreign body granuloma mimicking recurrence of malignant pleural mesothelioma

A 72-year-old man visited our hospital due to right pleural effusion. He had worked as a welder at a shipbuilding company and had been exposed to asbestos. Cytological examination and thoracoscopic pleural biopsy yielded a diagnosis of epithelial malignant pleural mesothelioma (MPM); extrapleural pn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakasuka, Takamasa, Fujimoto, Nobukazu, Hara, Naofumi, Miyamoto, Yosuke, Yamagishi, Tomoko, Asano, Michiko, Nishi, Hideyuki, Kishimoto, Takumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681966/ https://www.ncbi.nlm.nih.gov/pubmed/26744667 http://dx.doi.org/10.1016/j.rmcr.2015.09.002

Ejemplares similares

Lymphoproliferative disorder in pleural effusion in a subject with past asbestos exposure
por: Hara, Naofumi, et al.
Publicado: (2015)

Physician requests by patients with malignant pleural mesothelioma in Japan
por: Nagamatsu, Yasuko, et al.
Publicado: (2019)

Phrenic Nerve Paralysis as the Initial Presentation in Pleural Sarcomatoid Mesothelioma
por: Makimoto, Go, et al.
Publicado: (2014)

Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma
por: Fujimoto, Nobukazu, et al.
Publicado: (2014)

Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study
por: Nagamatsu, Yasuko, et al.
Publicado: (2018)

An appropriate choice for immunotherapy in malignant pleural mesothelioma
por: Fujimoto, Nobukazu
Publicado: (2020)

Bilateral Pleural Effusions as an Initial Presentation in Primary Sjögren's Syndrome
por: Makimoto, Go, et al.
Publicado: (2012)

Spare the lung: surgical treatment approach for malignant pleural mesothelioma
por: Fujimoto, Nobukazu
Publicado: (2023)

Significance of secretory leukocyte peptidase inhibitor in pleural fluid for the diagnosis of benign asbestos pleural effusion
por: Kishimoto, Takumi, et al.
Publicado: (2021)

Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
por: Hotta, Katsuyuki, et al.
Publicado: (2020)

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
por: Miyamoto, Yosuke, et al.
Publicado: (2021)

Adenocarcinoma of the Lung Acquiring Resistance to Afatinib by Transformation to Small Cell Carcinoma: A Case Report
por: Nishimura, Jun, et al.
Publicado: (2017)

Esophagobronchial Fistula in a Patient with Squamous Cell Carcinoma of the Lung: A Case Report
por: Ozeki, Taichi, et al.
Publicado: (2017)

Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report
por: Tanaka, Takaaki, et al.
Publicado: (2022)

Endobronchial T-cell lymphoma in a patient with chronic pyothorax
por: Matsumoto, Shinsaku, et al.
Publicado: (2015)

Retrospective investigation on diagnostic process for benign asbestos pleural effusion (BAPE) using checklist
por: Kishimoto, Takumi, et al.
Publicado: (2020)

Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients
por: Kishimoto, Takumi, et al.
Publicado: (2019)

Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma
por: Sakakibara-Konishi, Jun, et al.
Publicado: (2020)

Pleural tuberculosis mimicking malignant mesothelioma
por: Dawood, Wajahat, et al.
Publicado: (2019)

Intrapleural silicone granuloma mimicking pleural malignancy
por: Vo, Kiet, et al.
Publicado: (2021)

Clinical Investigation of Benign Asbestos Pleural Effusion
por: Fujimoto, Nobukazu, et al.
Publicado: (2015)

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma
por: AMATYA, VISHWA JEET, et al.
Publicado: (2012)

A patient with epithelioid pleural mesothelioma (Myxoid variant) who survived for a long period without treatment
por: Mizuhashi, Keiichi, et al.
Publicado: (2021)

Successful Treatment with Pemetrexed, Carboplatin, and Bevacizumab for Platinum-Resistant Adenocarcinoma of the Lung
por: Wada, Sae, et al.
Publicado: (2012)

Chondrosarcoma of the Rib Mimicking Malignant Pleural Mesothelioma
por: Furukawa, Masashi, et al.
Publicado: (2016)

Functional Properties of CD8(+) Lymphocytes in Patients with Pleural Plaque and Malignant Mesothelioma
por: Kumagai-Takei, Naoko, et al.
Publicado: (2014)

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma
por: Nakagawa, Kazuhiko, et al.
Publicado: (2021)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study
por: Fujimoto, Nobukazu, et al.
Publicado: (2020)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Foreign body reaction granuloma mimicking an aggressive tumor of the mandible
por: Kammoun, Rym, et al.
Publicado: (2023)

Malignant pleural mesothelioma in Italy
por: Bianchi, Claudio, et al.
Publicado: (2009)

Pleural mesothelioma – case report
por: Klawiter, Anna, et al.
Publicado: (2010)

Heterogeneity in Malignant Pleural Mesothelioma
por: Oehl, Kathrin, et al.
Publicado: (2018)

Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020)

Malignant pleural mesothelioma: an update
por: Hajj, Glaucia N. M., et al.
Publicado: (2021)

Malignant pleural mesothelioma in situ
por: Ando, Kohei, et al.
Publicado: (2022)

Extrathoracic Metastases in Pleural Mesothelioma
por: Dagogo-Jack, Ibiayi, et al.
Publicado: (2023)

Pleural Mesothelioma in the Era of Immunotherapy
por: Chevallier, Mathieu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tcgqt99860e589ph346k5dlrrb